Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Post by Chemicalon Dec 02, 2020 4:21am
423 Views
Post# 32016137

just few updates

just few updates
What Is Skin Lightening Cream? Published on November 30, 2020
https://www.verywellhealth.com/skin-lightening-creams-5085383
"Most brightening creams contain ingredients like hydroquinone, corticosteroids,
and mercury. These components each come with documented health risks."
 
The skin lightening industry’s history of colorism and the impact of Black Lives Matter. November 29, 2020
https://qz.com/africa/1939107/black-lives-matters-impact-on-skin-lightener-marketing-colorism/
"They ranked among the world’s most popular cosmetics and often contained mercury."
 
Johnson & Johnson – Black Lives Matter’s influence on pores and skin lightener advertising and marketing. November 30, 2020
https://fintechzoom.com/fintech_news_johnson-johnson/johnson-johnson-black-lives-matters-impact-on-skin-lightener-marketing-colorism-fintech-zoom/
"L’Oreal, the world’s largest cosmetics firm, will take away references to “white”, “fair” and “light” from advertising and marketing its
Garnier pores and skin merchandise."
 
challenges China’s love for ‘tall, light and skinny’ 29 NOVEMBER 2020
https://hongkongfp.com/2020/11/29/congolese-model-harmony-anne-marie-ilunga-challenges-chinas-love-for-tall-light-and-skinny/ 
“I started lightening my skin, using lightening products… Just so that I could fit into society’s norms,” Ilunga explained."
 
AstraZeneca's Forxiga approved in Japan for chronic heart failure. 02 December 2020
https://www.biospectrumasia.com/news/97/17211/astrazenecas-forxiga-approved-in-japan-for-chronic-heart-failure.html
"AstraZeneca’s Forxiga (dapagliflozin) has been approved in Japan for the treatment of patients with chronic heart
failure (HF) who are receiving standard of care." 
<< Previous
Bullboard Posts
Next >>